In a rodent disuse-induced osteoporosis model, DZCE treatment improved bone strength and prevented trabecular microstructural degradation, and reduced the levels of bone turnover markers, including TRAcP, DPD, and OC (Pan et al., 2014). The gene discussed is ACP5; the disease is osteoporosis.